TNM Classification

Dana Hartl, Sophie Leboulleux, Julien Hadoux, Amandine Berdelou, Ingrid Breuskin, Joanne Guerlain, Martin Schlumberger

    Résultats de recherche: Le chapitre dans un livre, un rapport, une anthologie ou une collection!!ChapterRevue par des pairs

    1 Citation (Scopus)

    Résumé

    Differentiated thyroid cancer (DTC) is being diagnosed with increasing incidence, but the mortality rate has remained low. The vast majority of these tumors are low-risk cancers, limited to the thyroid gland, which have a 20-year disease-specific survival rate close to 100%. Current recommendations aim to adapt adjuvant therapy and follow-up to each patient and each cancer, avoiding overtreatment and oversurveillance of indolent disease while escalating therapy for cancers with a high risk of recurrence and/or death. Current treatment paradigms will avoid unnecessary acute toxicity and long-term side effects associated with radioactive iodine (RAI) and thyroid hormone replacement therapy while effectively diagnosing and treating patients with distant metastases (DM) with appropriate techniques and drugs, improving quality of life and progression-free survival. Current classifications divide patients into risk groups that determine the extent of recommended adjuvant therapy and follow-up.

    langue originaleAnglais
    titreSurgery of the Thyroid and Parathyroid Glands
    EditeurElsevier
    Pages440-446
    Nombre de pages7
    ISBN (Electronique)9780323661270
    ISBN (imprimé)9780323661287
    Les DOIs
    étatPublié - 1 janv. 2021

    Contient cette citation